NO144925C - Analogifremgangsmaate ved fremstilling av terapeutisk aktivt bis-(2-methyl-3-hydroxy-4-hydroxymethyl-5-mercaptomethyl-pyridinium)-ethan-1,2-disulfonat - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktivt bis-(2-methyl-3-hydroxy-4-hydroxymethyl-5-mercaptomethyl-pyridinium)-ethan-1,2-disulfonat

Info

Publication number
NO144925C
NO144925C NO761367A NO761367A NO144925C NO 144925 C NO144925 C NO 144925C NO 761367 A NO761367 A NO 761367A NO 761367 A NO761367 A NO 761367A NO 144925 C NO144925 C NO 144925C
Authority
NO
Norway
Prior art keywords
disulphonate
mercaptomethyl
pyridinium
ethane
hydroxymethyl
Prior art date
Application number
NO761367A
Other languages
English (en)
Norwegian (no)
Other versions
NO144925B (no
NO761367L (xx
Inventor
Conrad Peter Dorn
Howard Jones
David Penman Jacobus
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO761367L publication Critical patent/NO761367L/no
Publication of NO144925B publication Critical patent/NO144925B/no
Publication of NO144925C publication Critical patent/NO144925C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • C07D213/66One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
    • C07D213/672-Methyl-3-hydroxy-4,5-bis(hydroxy-methyl)pyridine, i.e. pyridoxine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO761367A 1975-05-09 1976-04-22 Analogifremgangsmaate ved fremstilling av terapeutisk aktivt bis-(2-methyl-3-hydroxy-4-hydroxymethyl-5-mercaptomethyl-pyridinium)-ethan-1,2-disulfonat NO144925C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57605575A 1975-05-09 1975-05-09

Publications (3)

Publication Number Publication Date
NO761367L NO761367L (xx) 1976-11-10
NO144925B NO144925B (no) 1981-08-31
NO144925C true NO144925C (no) 1981-12-09

Family

ID=24302783

Family Applications (1)

Application Number Title Priority Date Filing Date
NO761367A NO144925C (no) 1975-05-09 1976-04-22 Analogifremgangsmaate ved fremstilling av terapeutisk aktivt bis-(2-methyl-3-hydroxy-4-hydroxymethyl-5-mercaptomethyl-pyridinium)-ethan-1,2-disulfonat

Country Status (29)

Country Link
JP (1) JPS51138684A (xx)
AR (1) AR210883A1 (xx)
AT (1) AT348691B (xx)
AU (1) AU1342876A (xx)
BE (1) BE841593A (xx)
BG (1) BG25218A3 (xx)
CA (1) CA1088542A (xx)
CH (1) CH625222A5 (xx)
CS (1) CS189003B2 (xx)
DD (1) DD125482A5 (xx)
DE (1) DE2620325C3 (xx)
DK (1) DK143335C (xx)
ES (1) ES447717A1 (xx)
FI (1) FI61881C (xx)
FR (1) FR2310130A1 (xx)
GB (1) GB1490688A (xx)
GR (1) GR59817B (xx)
HU (1) HU172048B (xx)
IE (1) IE43030B1 (xx)
IL (1) IL49466A (xx)
LU (1) LU74892A1 (xx)
NL (1) NL7604285A (xx)
NO (1) NO144925C (xx)
NZ (1) NZ180691A (xx)
PL (1) PL100306B1 (xx)
PT (1) PT65061B (xx)
RO (1) RO68526A (xx)
SE (1) SE427033B (xx)
ZA (1) ZA762750B (xx)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1695428C3 (de) * 1967-06-08 1978-10-05 Merck Patent Gmbh, 6100 Darmstadt Derivate des 5-Mercaptopyridoxins und Verfahren zu deren Herstellung
US3852454A (en) * 1973-06-15 1974-12-03 Merck & Co Inc Treatment of rheumatoid arthritis

Also Published As

Publication number Publication date
CS189003B2 (en) 1979-03-30
IL49466A0 (en) 1976-06-30
DE2620325C3 (de) 1979-08-02
SE7604580L (sv) 1976-11-10
PT65061A (en) 1976-05-01
SE427033B (sv) 1983-02-28
DK143335C (da) 1981-12-14
PL100306B1 (pl) 1978-09-30
IE43030L (en) 1976-11-09
BG25218A3 (en) 1978-08-10
DK179376A (da) 1976-11-10
FR2310130B1 (xx) 1979-09-28
IL49466A (en) 1979-05-31
NO144925B (no) 1981-08-31
ATA335676A (de) 1978-07-15
CH625222A5 (en) 1981-09-15
FI61881C (fi) 1982-10-11
NZ180691A (en) 1978-07-28
GR59817B (en) 1978-03-02
FR2310130A1 (fr) 1976-12-03
IE43030B1 (en) 1980-12-03
AU1342876A (en) 1977-11-03
NL7604285A (nl) 1976-11-11
LU74892A1 (xx) 1977-02-11
AR210883A1 (es) 1977-09-30
FI61881B (fi) 1982-06-30
FI761084A (xx) 1976-11-10
DE2620325A1 (de) 1976-11-18
JPS51138684A (en) 1976-11-30
ZA762750B (en) 1977-12-28
DE2620325B2 (de) 1978-11-16
DK143335B (da) 1981-08-10
ES447717A1 (es) 1978-04-01
RO68526A (ro) 1981-08-30
NO761367L (xx) 1976-11-10
PT65061B (en) 1977-04-03
BE841593A (fr) 1976-11-08
HU172048B (hu) 1978-05-28
AT348691B (de) 1979-02-26
CA1088542A (en) 1980-10-28
DD125482A5 (xx) 1977-04-20
GB1490688A (en) 1977-11-02

Similar Documents

Publication Publication Date Title
NO152215C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4,5-diaryl-2-nitroimidazoler
NO166320C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tetrazolderivater.
NO145379C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n2-arylsulfonyl-l-argininamider.
NO151040C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-halogenpyrimid-2-oner
NO146095C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinazolin-derivater
NO146359C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cyproheptadinderivater
NO145198C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktivt 1,2-benzisotia-zolinon-3
NO152414C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2,6-dialkoksybenzamider
NO146060C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-substituerte-5-alkylresorcinol
NO147150C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive piperidiner.
NO144457C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydro-1,4-pyridiner
NO151660C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolderivater.
NO145163C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive antitumorglykosider
NO145620C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive depotsteroidestere.
NO150158C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 6,7-dimetoksyquinazolinderivater
NO146863C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive alkyltiofenoksyalkylaminer
NO146777C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 6h-indolo (3,2,1-de)-(1,5)-naftyridinderivater
NO147485C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 8-aminomethylisoflavonderivater
NO149960C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive bis(nitrosoureido)-polyolderivater
NO143903C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-fluorpyrimidin-4-on-derivater
NO154088C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive tetrahydrokinoliner.
NO144149C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktivt bis-(2-methyl-3-hydroxy-4-hydroxymethyl-pyrid-5-yl-methyl)-carbodithioat
NO152839C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.
NO144741C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiopyrano-pyrazoler
NO153221C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 6-metoksy-alfa-karboksypenicilliner.